Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Immuron Ltd changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 5 | 7 | +2 |
| Shares | 183.6K | 171.8K | −11.8K (−6.5%) |
| Value | $728.0K | $429.5K | −$298.5K (−41.0%) |
New holders (2)
Institutions that held Immuron Ltd at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 14,615 | $37.0K | 0.00% |
| Stephens Consulting, LLC | 3,000 | $7.50K | 0.01% |
Sold out (0)
Institutions that held Immuron Ltd at the end of Q3 2021 and filed for Q4 2021 without it.
None.